Pharma

Your Article Summary

See Latest Articles

First Patient Enrolled in Phase 3 Trials of Genzyme Oral Capsule for Gaucher Disease
Genzyme, 10/21/09

Genzyme Corporation announced that the company has begun enrollment in the first of two global, multi–center, phase 3 trials of Genz–112638, a potential new oral therapy for Gaucher disease type 1. The two multi–national, multi–center trials are being conducted to evaluate the safety and efficacy of the small molecule.

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09

A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimers disease: a post hoc analysis
Current Medical Research and Opinion, 11/25/09

Pandemic 2009 Influenza Update: Pandemrix data in children and adolescents from 3 to 17 years of age
GlaxoSmithKline, 11/24/09

 See all of Drug Trials